These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8383742)

  • 1. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
    McCabe RT; Wasterlain CG; Kucharczyk N; Sofia RD; Vogel JR
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1248-52. PubMed ID: 8383742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of felbamate with [3H]DCKA-labeled strychnine-insensitive glycine receptors in human postmortem brain.
    Wamsley JK; Sofia RD; Faull RL; Narang N; Ary T; McCabe RT
    Exp Neurol; 1994 Oct; 129(2):244-50. PubMed ID: 7957739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Felbamate block of the N-methyl-D-aspartate receptor.
    Subramaniam S; Rho JM; Penix L; Donevan SD; Fielding RP; Rogawski MA
    J Pharmacol Exp Ther; 1995 May; 273(2):878-86. PubMed ID: 7752093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Felbamate modulates the strychnine-insensitive glycine receptor.
    White HS; Harmsworth WL; Sofia RD; Wolf HH
    Epilepsy Res; 1995 Jan; 20(1):41-8. PubMed ID: 7713059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Felbamate increases [3H]glycine binding in rat brain and sections of human postmortem brain.
    McCabe RT; Sofia RD; Layer RT; Leiner KA; Faull RL; Narang N; Wamsley JK
    J Pharmacol Exp Ther; 1998 Aug; 286(2):991-9. PubMed ID: 9694960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of some convulsant agents on the protective activity of a novel antiepileptic drug, felbamate, against maximal electroshock in mice.
    Swiader M; Gasior M; Wielosz M; Czuczwar SJ
    Pol J Pharmacol; 2003; 55(4):649-53. PubMed ID: 14581726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitoprotective effect of felbamate in cultured cortical neurons.
    Kanthasamy AG; Matsumoto RR; Gunasekar PG; Trunong DD
    Brain Res; 1995 Dec; 705(1-2):97-104. PubMed ID: 8821739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neuropharmacological evaluation of felbamate as a novel anticonvulsant.
    White HS; Wolf HH; Swinyard EA; Skeen GA; Sofia RD
    Epilepsia; 1992; 33(3):564-72. PubMed ID: 1592038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
    De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
    Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular Ca2+ concentration.
    Taylor LA; McQuade RD; Tice MA
    Eur J Pharmacol; 1995 Apr; 289(2):229-33. PubMed ID: 7621896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Felbamate: interaction with glycine receptors in human cerebral cortex.
    Wamsley JK; Sofia RD; Faull RL; Narang N; Ary T; Gan XD; McCabe RT
    Proc West Pharmacol Soc; 1994; 37():81-3. PubMed ID: 7984680
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning.
    Chiamulera C; Costa S; Reggiani A
    Psychopharmacology (Berl); 1990; 102(4):551-2. PubMed ID: 1982904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strychnine-insensitive glycine site antagonists attenuate a cardiac arrest-induced movement disorder.
    Matsumoto RR; Nguyen D; Truong DD
    Eur J Pharmacol; 1995 Mar; 275(2):117-23. PubMed ID: 7796845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice.
    De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
    Pharmacol Biochem Behav; 1996 Oct; 55(2):281-7. PubMed ID: 8951966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats.
    Swinyard EA; Sofia RD; Kupferberg HJ
    Epilepsia; 1986; 27(1):27-34. PubMed ID: 3004930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Felbamate pharmacology and use in epilepsy.
    Burdette DE; Sackellares JC
    Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of felbamate, kynurenic acid derivatives and NMDA antagonists on in vitro kainate-induced epileptiform activity.
    Domenici MR; Marinelli S; Sagratella S
    Life Sci; 1996 May; 58(26):PL391-6. PubMed ID: 8691980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycine reversal of felbamate hypoxic protection.
    Wallis RA; Panizzon KL
    Neuroreport; 1993 Jul; 4(7):951-4. PubMed ID: 8103685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective antagonism of the anticonvulsant effects of felbamate by glycine.
    Coffin V; Cohen-Williams M; Barnett A
    Eur J Pharmacol; 1994 Apr; 256(2):R9-10. PubMed ID: 8050461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.